Abstracts from the 38th Annual Meeting of the Society of General Internal Medicine by Rao, Bharat et al.
Abstracts from the 38th Annual Meeting
of the Society of General
Internal Medicine




“WE ALL HAVE DIFFERENT STORIES”: VETERANS’ EXPERIENCES AND
PREFERENCES FOR PROACTIVE IN-BETWEEN VISIT CARE Ashley E.
Jensen1, 2; Nicole Skursky1; Erica Sedlander1; Katherine Barboza1; Katelyn Bennett1, 2;
Scott Sherman2, 1; Mark D. Schwartz2, 1. 1NYU School of Medicine, New York, NY;
2VHA New York Harbor Healthcare System, New York, NY. (Tracking ID #2198048)
BACKGROUND:Medical home models, like VA’s Patient Aligned Care Team (PACT)
seek to engage patients via proactive outreach for prevention and chronic disease man-
agement (panel management). We know little about patients’ perspectives, experiences
and preferences in receiving this type of non-face-to-face care. To address this gap and
inform future implementation efforts, we conducted a qualitative study of veterans at two
VA campuses.
METHODS: We conducted a qualitative study of veterans with hypertension or current
smoking, who had participated in a cluster-randomized trial of panel management support
in which Panel Management Assistants provided outreach and coaching to veterans. We
recruited eligible patients by mail and phone, who were invited to participate in focus
groups stratified by hospital, gender (six male and four female groups), and age (under or
over age 60). Participants completed brief questionnaires to ascertain their health status
and supplemental demographic information. Discussion questions focused on facilitators
and barriers to healthy behavior change, experience with proactive outreach, and prefer-
ences for receiving care in-between visits. Each focus group was audio recorded and
transcribed, and supplemental field notes were taken. A subset of transcripts was reviewed
independently by four researchers, who then created an initial consensus codebook. Two
researchers independently coded each transcript, modified the codebook as new themes
emerged, and met to reconcile coding. Nvivo software was used for analysis.
RESULTS: A total of 1179 patients were invited, 127 were scheduled to attend, and 77
participated. Participants had a mean age of 59 years, were predominantly African
American (64 %), and completed at least some college (57 %) with 29 % reporting that
they worked outside the home. Most participants had hypertension (78 %), and smoked at
least 100 cigarettes in their lifetime (77 %). Participants generally appreciated existing
efforts to provide care in between visits including post-discharge phone calls and reminder
letters. As one veteran put it, “I don’t mind somebody calling and checking up on me
because that’s letting me know that you care....” Participants were receptive to additional
outreach for referral, reminders and motivational support in between visits. However, they
felt that these outreach efforts should be tailored to their needs and preferences in terms of
frequency, content and mode of contact and some had concerns about privacy. Although
many participants were open to non-clinicians contacting them as long as they had strong
communication skills, empathy, connection to PC teams and training, many felt that the
individual should be a veteran or at least able to relate to their military experience.
Avoiding medications was a consistent motivator for making lifestyle changes and female
veterans in particular wanted access to more holistic health options either at the VA or
within their communities.
CONCLUSIONS: Our findings indicate that veterans are receptive to proactive
outreach for prevention and management of chronic conditions, especially when
this outreach is personalized and flexible. This study has important limitations
as it was restricted only to veterans and those agreeing to attend a focus group.
However, the information gathered from this study will be useful to inform the
design of future panel management efforts.
“I JUST WANT MY DOCTOR’S UNDIVIDED ATTENTION”: PATIENT PER-
CEPTIONS OF THE IMPACT OF EMR USE ON COMMUNICATION Obiama
Ukabiala3; Wei Wei Lee1; Lollita Alkureishi1; Laura Ruth Venable2; Samantha Ngooi2;
Jeanne M. Farnan1; Vineet M. Arora1. 1University of Chicago, Chicago, IL; 2University
of Chicago Medical Center, Chicago, IL; 3Pritzker School of Medicine, Chicago, IL.
(Tracking ID #2196181)
BACKGROUND: The use of the Electronic Medical Record (EMR) in exam
rooms can impede the doctor-patient relationship. Little research to date has
explored patient perceptions of provider EMR use and the impact on commu-
nication. Despite widespread EMR use, few curricula teach providers how to
use the EMR to enhance communication with patients. The aims of our study
are to identify patients’ perceptions of EMR use and elicit their suggestions to
inform development of a patient-centered EMR use curriculum.
METHODS: Patients seen by internal medicine attendings and residents at the University
of Chicago’s primary care clinic were randomly selected for our study. One year after EMR
implementation, trained research assistants conducted structured telephone interviews with
patients using critical incident technique and appreciative inquiry to elicit their positive and
negative perceptions of EMRuse by physicians. Using constant comparative analysis, three
investigators independently coded 10 % of the transcripts to develop the coding library. An
additional 10 % of the transcripts were coded to establish inter-rater reliability. The coding
library was applied to the remainder of the transcripts for analysis using ATLAS.ti software.
RESULTS: Of the 384 patients selected, 12 were excluded due to disability, language
barriers, or death. Of the 372 eligible patients, 113 telephone interviews were completed.
The interviews revealed two overarching themes: (1) Clinical Functions of EMR (2)
Communication functions of EMR. Six subthemes were identified: (1) Documentation
functions of the EMR (2) Clinical Workflow functions of EMR (3) EMR as educational
resource (4) Information access, (5) Facilitate Engagement and (6) Physical focus. To date
we have analyzed 58% (56/113) of the transcripts. Overall, 84 % (576/687) of total codes
reflected positive perceptions of EMR. The majority of the positive perceptions fell under
the “Clinical Workflow Functions of EMR” subtheme (i.e. ‘increases clinical efficiency’
and ‘promotes teamwork and communication between doctors’). For example one patient
said ‘they can see all the other doctors’ notes… they really work together as a team. I love
it!’ Only 16 % (111/687) of the codes represented negative perceptions. Interestingly,
45 % (50/111) of negative codes fell under the “Physical Focus” subtheme (i.e. “poor eye
contact” and “unbalanced focus”). For example one patient stated ‘how can you focus on
the patient if you’re looking somewhere else… it gets in the way.’
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4476 IU/L and low haptoglobin of <8 mg/dL. The peripheral blood smear showed
schistocytes and fragmented red blood cells, compatible with microangiopathic hemolytic
anemia (MAHA). The patient was started on steroids for suspected autoimmune hemolytic
anemia. However, Coombs test was negative, and her hemoglobin responded appropri-
ately to multiple transfusions of packed red blood cells, therefore steroids were
discontinued. An extensive hematological workup eventually revealed severe B12 defi-
ciency with positive intrinsic factor antibodies. The patient was treated with subcutaneous
B12 injections and had near normalization of her hematological indices within 3 weeks of
initiating treatment.
DISCUSSION: RBC fragmentation and destruction associated with severe vitamin B12
deficiency is a relatively rare and underreported phenomenon. It is attributed to ineffective
erythropoiesis leading to intramedullary hemolysis. This type of “pseudo-thrombotic
microangiopathy” is commonlymisdiagnosed and treated as TTP. One small retrospective
study has found that the pseudo-thrombotic microangiopathy has been associated with
lower reticulocyte counts and higher LDH levels than true TTP, as was seen in our case.
SEVERE MYELOSUPPRESION SECONDARY TO ACCIDENTAL DAILY
METHOTREXATE Bharat Rao; Shahzaib Nabi; Rohit Gulati; Michael H. Lazar. Henry
Ford Hospital, Detroit, MI. (Tracking ID #2189080)
LEARNINGOBJECTIVE #1: Early recognition and treatment of methotrexate toxicity
and associated myelosuppresion.
LEARNING OBJECTIVE #2: Importance of medication reconcillation in patient care.
CASE: A 67-year-old Hispanic female presented with a 5-day history of bleeding sores
from her mouth, pain on swallowing, watery diarrhea, and fatigue. She has a history of
breast cancer diagnosed and treated 10 years ago with lumpectomy, chemotherapy, and
radiation. She also has a significant history of psoriasis and diabetes mellitus type 2. She
has no personal or family history of autoimmune diseases, leukemia, or lymphoma. She
reported taking an unknown medication for psoriasis. On exam, she was febrile and
tachycardic. She had erosions of lips with associated bleeding and oral ulcerations. Her
abdominal exam revealed mild diffuse tenderness but no hepatosplenomegaly. Lab work
revealed pancytopenia that decreased progressively to WBC 0.4 billion cells/L (ANC 0),
hemoglobin 6.6 g/dL, and platelet count 17 billion/L. Other remarkable initial labs
included elevated transaminases (AST 183 U/L, ALT 157 U/L). The initial differential
diagnosis included acute leukemia, drug induced pancytopenia, and infectious processes.
Broad-spectrum antibiotics were initiated during admission for neutropenic fever. Initial
infectious work-up was negative. Further hematologic labs revealed normal iron studies
and vitamin B12 level, low reticulocyte count and low folate (4.7 ng/ml). She underwent a
bone marrow biopsy, which revealed marked trilineage hypolastic bone marrow without
definitive evidence of lymphoproliferative disease. She did receive blood transfusions
given low hemoglobin. On day five the patient’s family brought her medications along
with her pillbox. It was discovered she was prescribed methotrexate 10 mg weekly.
However, on inspection of her weekly pillbox, she was noted to have a methotrexate
tablet for each day. A presumptive diagnosis of methotrexate toxicity was given. She was
immediately initiated on intravenous folinic acid treatment. Methotrexate level was
ordered on day five of admission, and returned<0.10 umol/L; however this was several
days after her last exposure. Given she still had diarrhea and persistent fevers, a CT
abdomen was ordered to rule out enterocolitis; it revealed cholelithiasis, with mild fat
stranding surrounding the gallbladder. This was followed by a HIDA scan with findings
consistent with acute cholecystitis. She also had urinalysis that was positive for ampicillin-
resistant and vancomycin-resistant enterococcus. Clostridium dificile testing was negative
during admission. Although she was clinically asymptomatic from gallstones at the time
of imaging, it was decided to pursue cholecystostomy placement in light of her neutrope-
nia and persistent fevers. Her antibiotic coverage was changed to cefepime and metroni-
dazole for cholecystitis, and daptomycin for the enterococcus. In addition, the decision
was made to administer her granulocyte-colony stimulating factor. During her clinical
course, she showed gradual symptomatic improvement and her blood counts increased.
Upon follow-up with hematology as an outpatient, her blood counts had normalized and
she was reportedly doing well.
DISCUSSION:Methotrexate has been used as a treatment of psoriasis for many years and
is generally prescribed as a low dose taken weekly. Generally, severe side effects are rare
when taken as prescribed and with folic acid supplementation. This case highlights several
clinical clues to identifying methotrexate toxicity including stomatitis, GI symptoms,
fatigue, fever and transaminitis. However, it is important to recognize that fever should
not be soley attributed to drug induced toxicity, and that infectious etiologies should be
ruled out. Her labs showed low folate secondary to methotrexate’s antagonist effect on
dihydrofolate reductase and replacement is one of the mainstays of overdose treatment.
Myelosuppresion, as in this case, can be fatal and treatment should focus on rapid
identification and treatment of an underlying etiology, empiric antibiotic coverage for
neutropenic fever, supportive transfusions as needed, and consideration of granulocyte
stimulating factors.Moreover, one of the most important learning points in this case is that
a thorough medication review including efforts to identify unknown medications or non-
traditional medications might lead to an earlier diagnosis. It is also important to ensure
patient understanding of medication doses and frequency upon prescribing in order to
prevent severe adverse events like in this case.
SEVERE PULMONARY HYPERTENSION FROM CHRONIC, UNTREATED
POLYMYOSITIS WITHOUT INTERSTITIAL LUNG DISEASE Benjamin
Barbash2; David M. Levine2; Natalie K. Levy1. 1NYU School of Medicine, Bellevue
Hospital, New York, NY; 2New York University School of Medicine, New York, NY.
(Tracking ID #2196353)
LEARNING OBJECTIVE #1: Describe the natural history of polymyositis
LEARNINGOBJECTIVE #2: Formulate a differential diagnosis for shortness of breath
in patients with polymyositis
CASE: A 68 year-old female with hypertension, osteoporosis, and polymyositis (PM)
presented with two weeks of severe shortness of breath at rest. Eight years prior she
developed quadriceps weakness, which gradually progressed such that she became bed-
bound 3 years prior. PMwas diagnosed by a neuromuscular specialist 7 months prior, after
deltoid muscle biopsy demonstrated degenerative muscle fibers without inclusions, con-
sistent with chronic PM. Daily high-dose prednisone was started 6 months prior to
admission, but the patient was subsequently lost to follow-up. Her exam revealed 95 %
saturation on 4 L oxygen with rapid, shallow breaths, accessory muscle use, 1/5 bilateral
proximal muscle strength, and 5/5 distal muscle strength. TTE demonstrated moderate-to-
severe pulmonary hypertension (PH), severe right ventricular dilatation, preserved LVEF,
and no anatomic defects or shunting. Chest CTand V/Q scan showed no thromboembolic
disease and no interstitial lung disease (ILD). Right heart catheterization demonstrated
pulmonary artery pressure 68/19 mmHg, wedge pressure 12 mmHg (no vasodilator
response). Sleep study ruled out OSA. FEV1 was 0.55 L, FVC 0.69 L, FEV1/FVC
79 %, DLCO 3.7 mL/mmHg/min (normal is 15.8 mL/mmHg/min), and mean inspiratory
pressure -17cmH20 (normal range -65cmH20 to -95cmH20). Labs showed normal serum
ESR, CRP, CPK, aldolase, negative antibodies to Jo-1, scl70, anti centromere, SSA, SSB,
RNP, and smith. ANA and dsDNAwere both weakly positive (1:40 [nucleolar] and 11 IU/
mL, respectively). A trial of mycophenolate mofetil and prednisone provided no symp-
tomatic improvement. Physical therapy and overnight bilevel offered minimal symptom-
atic relief.
DISCUSSION: Our case highlights the natural history of PM and the importance of
maintaining a broad differential for SOB. PM is an idiopathic inflammatory myopathy
characterized by proximal skeletalmuscle weakness. Diagnostic criteria vary but generally
rely on clinical (symmetric proximal weakness), laboratory (elevated CK, aldolase, or
liver enzymes), electromyographic (irritable myopathy), radiographic (MRI with muscle
inflammation), and histologic (inflammatory infiltration) criteria. Patients are diagnosed
with definite, probable, or possible PM based on the number of criteria met. Our patient
regrettably represents the natural history of untreated PM: proximal muscle inflammation
and weakness that progresses to severe debilitation and non-viable muscle tissue. Active
disease is treated with steroids and/or immune modulator therapy. However, therapy has
limited value in longstanding disease, as in our patient. To our knowledge, this is the first
account of PH secondary to PMwithout the presence of ILD.While the association of PH
with various connective tissue diseases (particularly scleroderma) is well known, knowl-
edge of PM-induced PH is limited. Two other cases with ILD have been described, while 8
additional patients with overlap of PM-dermatomyositis and PM-Sjogrens have been
reported. The differential diagnosis for PH generally includes 5 groups: pulmonary arterial
hypertension, PH secondary to left heart disease, PH due to lung disease, PH from chronic
thromboembolic disease, and PH due to unclear multifactorial mechanisms. As our patient
lacked significant left heart disease and unclear pulmonary dysfunction, she required
PFTs, V/Q scan, polysomnography, autoimmune testing, and cardiac catheterization to
rule out all but the last of these groups, leaving PM the cause of her PH. While the
pathophysiology of PM-induced PHwithout ILD is not well understood, we postulate that
diaphragmatic weakness causes poor lung expansion, atelectasis, and chronic hypoxemia,
with ensuing PH. Our case illustrates the importance of early recognition of PM and is the
first account of PM-induced PH in the absence of ILD.
SEVERE THROMBOCYTOPENIA CAUSED BY NASH Gen Yamada2;
Christine Kwan1, 2. 1Teine Keijinkai Hospital, Arlington, TX; 2Teine Keijinkai
Hospital, Sapporo, Japan. (Tracking ID #2199817)
LEARNING OBJECTIVE #1: Recognize that severe thrombocytopenia can be caused
by nonalcoholic steatohepatitis (NASH)
CASE: A 39-year-old Asian woman is transferred for possible splenectomy. She initially
visits her primary care physician 5 weeks ago with gingival bleeding and purpura for
which blood tests show platelet counts <2000 / L and slightly elevated liver function tests.
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